GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OCSE:COLO B) » Definitions » EBITDA Margin %

Coloplast AS (OCSE:COLO B) EBITDA Margin % : 31.04% (As of Mar. 2025)


View and export this data going back to 1993. Start your Free Trial

What is Coloplast AS EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Coloplast AS's EBITDA for the three months ended in Mar. 2025 was kr2,151 Mil. Coloplast AS's Revenue for the three months ended in Mar. 2025 was kr6,930 Mil. Therefore, Coloplast AS's EBITDA margin for the quarter that ended in Mar. 2025 was 31.04%.


Coloplast AS EBITDA Margin % Historical Data

The historical data trend for Coloplast AS's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS EBITDA Margin % Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.23 36.29 32.02 31.56 31.37

Coloplast AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.30 31.90 30.65 32.75 31.04

Competitive Comparison of Coloplast AS's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, Coloplast AS's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Coloplast AS's EBITDA Margin % falls into.


;
;

Coloplast AS EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Coloplast AS's EBITDA Margin % for the fiscal year that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Sep. 2024 )/Revenue (A: Sep. 2024 )
=8480/27030
=31.37 %

Coloplast AS's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=2151/6930
=31.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Coloplast AS  (OCSE:COLO B) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Coloplast AS EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Coloplast AS's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines